Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer-Reference-Cited by-同舟云学术

Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer

Published:2017-10-30 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Solinas Cinzia,Garaud Soizic,De Silva Pushpamali,Boisson Anaïs,Van den Eynden Gert,de Wind Alexandre,Risso Paolo,Rodrigues Vitória Joel,Richard François,Migliori Edoardo,Noël Grégory,Duvillier Hugues,Craciun Ligia,Veys Isabelle,Awada Ahmad,Detours Vincent,Larsimont Denis,Piccart-Gebhart Martine,Willard-Gallo Karen

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference74 articles.

1. The use of immunotherapy in the treatment of melanoma;Achkar;J Hematol Oncol,2017

2. Understanding the checkpoint blockade in lung cancer immunotherapy;Dal Bello;Drug Discov Today,2017

3. Elements of cancer immunity and the cancer-immune set point;Chen;Nature,2017

4. Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: current state of the art;Solinas;Breast,2017

5. Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes;Desmedt;Clin Cancer Res,2008

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy;Expert Review of Clinical Immunology;2024-07-16

2. Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer;European Urology;2024-07

3. Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSs;Scientific Reports;2024-06-11

4. Prognostic and therapeutic model based on disulfidptosis-related genes for patients with clear cell renal cell carcinoma;Heliyon;2024-06

5. Tertiary lymphoid structure in oral squamous cell carcinoma: An institutional experience;Oral Oncology Reports;2024-06